Drug-induced skin toxicity: gaps in preclinical testing cascade as opportunities for complex in vitro models and assays
The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Abstract
Skin is the largest organ of the body and serves as the principle barrier to the environment. Composed of multiple cell types arranged in stratified layers with highly specialized appendages, it serves sensory and immune surveillance roles in addition to its primary mechanical function. Several complex in vitro models of skin (i.e. microphysiological systems (MPS) including but not limited to 3D tissues, organ-on-a-chip, organoids), have been developed and assays validated for regulatory purposes. As such, skin is arguably the most advanced organ with respect to model development and adoption across industries including chemical, cosmetic, and to a somewhat lesser extent, pharmaceutical. Early adoption of complex skin models and associated assays for assessment of irritation and corrosion spurred research into other areas such as sensitization, absorption, phototoxicity, and genotoxicity. Despite such considerable advancements, opportunities remain for immune capabilities, inclusion of appendages such as hair follicles, fluidics, and innervation, among others. Herein, we provide an overview of current complex skin model capabilities and limitations within the drug development scheme, and recommendations for future model development and assay qualification and/or validation with the intent to facilitate wider adoption of use within the pharmaceutical industry.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These consortia not only promote MPS and OoC adoption but also generate lists of reference compounds relevant to various organ systems (Ainslie et al., 2019; Baudy et al., 2020; Hardwick et al., 2020; Peters et al., 2020; Phillips et al., 2020; Pointon et al., 2021).”
From Considering future qualification for regulatory science in the early development of microphysiological systems: a case study of microthrombosis in a Vessel-on-Chip (2024) · cites this paper as Hardwick et al., 2020
Citations
Cites
Visualization and analysis of gene expression in tissue sections by spatial transcriptomics
Ståhl, P. L., Salmén, F., Vickovic, S., Lundmark, A., Navarro, J. F., Magnusson, J., Giacomello, S., Asp, M., Westholm, J. O., Huss, M., et al. (2016) · Science · doi:10.1126/science.aaf2403 · Cited by 3,834
Immune-related adverse events with immune checkpoint blockade: a comprehensive review
Michot, J. M., Bigenwald, C., Champiat, S., Collins, M., Carbonnel, F., Postel-Vinay, S., Berdelou, A., Varga, A., Bahleda, R., Hollebecque, A., et al. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2015.11.016 · Cited by 2,127
Pharmacologically induced selective degeneration of chemosensitive primary sensory neurones
JANCSÓ, G., KIRALY, E., & JANCSÓ-GÁBOR, A. (1977) · Nature · doi:10.1038/270741a0 · Cited by 1,282
Cytokine modulation of atopic dermatitis filaggrin skin expression
Howell, M. D., Kim, B. E., Gao, P., Grant, A. V., Boguniewicz, M., DeBenedetto, A., Schneider, L., Beck, L. A., Barnes, K. C., & Leung, D. Y. M. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.04.031 · Cited by 1,084
Casarett and Doull's Toxicology: The Basic Science of Poisons
TIMBRELL, J. A. (1981) · Biochemical Society Transactions · doi:10.1042/bst0090255a · Cited by 875
Immune self-reactivity triggered by drug-modified HLA-peptide repertoire
Illing, P. T., Vivian, J. P., Dudek, N. L., Kostenko, L., Chen, Z., Bharadwaj, M., Miles, J. J., Kjer-Nielsen, L., Gras, S., Williamson, N. A., et al. (2012) · Nature · doi:10.1038/nature11147 · Cited by 696
Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6
Kim, B. E., Leung, D. Y. M., Boguniewicz, M., & Howell, M. D. (2008) · Clinical Immunology · doi:10.1016/j.clim.2007.11.006 · Cited by 538
Globally Harmonized System of Classification and Labelling of Chemicals (GHS)
(2016) · Globally harmonized system of classification and labelling of chemicals · doi:10.18356/a6a925c3-en · Cited by 511
Cottrez, F., Boitel, E., Ourlin, J.-C., Peiffer, J.-L., Fabre, I., Henaoui, I.-S., Mari, B., Vallauri, A., Paquet, A., Barbry, P., et al. (2016) · Toxicology in Vitro · doi:10.1016/j.tiv.2016.01.007 · Cited by 499
Significance of Skin Barrier Dysfunction in Atopic Dermatitis
Kim, B. E., & Leung, D. Y. M. (2018) · Allergy, Asthma & Immunology Research · doi:10.4168/aair.2018.10.3.207 · Cited by 393
Research works printed but not linked: 17
- Abd, 2016, J. Clin. Pharmacol., 8, 163
- OECD , Explanatory background document to the OECD draft Test Guideline on in vitro skin irritation testing , 2010
- G. F. Gerberick , J. A.Troutman , L. M.Foertsch and P. S.Kern , in Alternatives for Dermal Toxicity Testing , ed. C. Eskes , E. Van Vliet and H. I. Maibach , Springer Cham , 2017 , pp. 225–233
- A. Natsh , in Alternatives for Dermal Toxicity Testing , ed. C. Eskes , E. Van Vliet and H. I. Maibach , Springer Cham , 2017 , pp. 235–248
- E. Corsini and V.Galbiati , in Alternatives for Dermal Toxicity Testing , ed. C. Eskes , E. Van Vliet and H. I. Maibach , Springer Cham , 2017 , pp. 263–272
- T. Ramirez , A.Mehling and R.Landsiedel , in Alternatives for Dermal Toxicity Testing , ed. C. Eskes , E. Van Vliet and H. I. Maibach , Springer Cham , 2017 , pp. 249–262
- D. Keller , C.Bauch and P.Patel , in Alternatives for Dermal Toxicity Testing , ed. C. Eskes , E. Van Vliet and H. I. Maibach , Spinger Cham , 2017 , pp. 377–391
- H. Sakaguchi and T.Ashikaga , in Alternatives for Dermal Toxicity Testing , ed. C. Eskes , E. Van Vliet and H. I. Maibach , Springer Cham , 2017 , pp. 289–309
- N. Alepee , C.Piroird and L.Nardelli , in Alternatives for Dermal Toxicity Testing , ed. C. Eskes , E. Van Vliet and H. I. Maibach , Spinger Cham , 2017 , pp. 311–330
- M. Lindstedt , K. S.Zeller , H.Johansson and C.Borrebaeck , in Alternatives for Dermal Toxicity Testing , ed. C. Eskes , E. Van Vliet and H. I. Maibach , Springer Cham , 2017 , pp. 393–403
- N. Lambrechts , G.Schoeters , R.Van Den Heuvel , H.Witters , I.Nelissen and J.Hooyberghs , in Alternatives for Dermal Toxicity Testing , ed. C. Eskes , E. Van Vliet and H. I. Maibach , Springer Cham , 2017 , pp. 347–359
- P. R. Esser and S. F.Martin , in Alternatives for Dermal Toxicity Testing , ed. C. Eskes , E. Van Vliet and H. I. Maibach , Springer Cham , 2017 , pp. 449–454
- S. Pfuhler and K.Reisinger , in Alternatives for Dermal Toxicity Testing , ed. C. Eskes , E. Van Vliet and H. I. Maibach , Springer Cham , 2017 , pp. 513–525
- K. Reisinger and S.Pfuhler , in Alternatives for Dermal Toxicity Testing , ed. C. Eskes , E. Van Vliet and H. I. Maibach , Springer Cham , 2017 , pp. 527–539
- H. Kandarova and M.Liebsch , in Alternatives for Dermal Toxicity Testing , ed. C. Eskes , E. van Vliet and H. I. Maibach , Springer Cham , 2017 , pp. 483–503
- H. Kojima , K.Hosoi and S.Onoue , in Alternatives for Dermal Toxicity Testing , ed. C. Eskes , E. Van Vliet and H. I. Maibach , Springer Cham , 2017 , pp. 477–482
- Coimbra, 2015, Ann. Transl. Med., 3, 76
Cited by
Organs-on-chips: into the next decade
Low, L. A., Mummery, C., Berridge, B. R., Austin, C. P., & Tagle, D. A. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0079-3 · Cited by 1,029
Organ-on-a-chip meets artificial intelligence in drug evaluation
Deng, S., Li, C., Cao, J., Cui, Z., Du, J., Fu, Z., Yang, H., & Chen, P. (2023) · Theranostics · doi:10.7150/thno.87266 · Cited by 260
Marx, U. (2020) · ALTEX · doi:10.14573/altex.2001241 · Cited by 218
“Members of the IQ Consortium recently published two manuscripts with recommendations for in vitro model development and assay qualification of lung and skin models to facilitate their wider adoption of use within the pharmaceutical industry (Ainslie et al., 2019; Hardwick et al. 2019).”
MethodKohl, Y., Rundén‐Pran, E., Mariussen, E., Hesler, M., Yamani, N. E., Longhin, E., & Dušinská, M. (2020) · Nanomaterials · doi:10.3390/nano10101911 · Cited by 123
Fabre, K., Berridge, B., Proctor, W. R., Ralston, S., Will, Y., Baran, S. W., Yoder, G., & Van Vleet, T. R. (2020) · Lab on a Chip · doi:10.1039/c9lc01168d · Cited by 116
Self-citationTowards in vitro models for reducing or replacing the use of animals in drug testing
Stresser, D. M., Kopec, A. K., Hewitt, P., Hardwick, R. N., Van Vleet, T. R., Mahalingaiah, P. K. S., O’Connell, D., Jenkins, G. J., David, R., Graham, J., et al. (2023) · Nature Biomedical Engineering · doi:10.1038/s41551-023-01154-7 · Cited by 94
Self-citationAlyoussef, A., El-Gogary, R. I., Ahmed, R. F., Ahmed-Farid, O. A.-H., Bakeer, R. M., & Nasr, M. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102360 · Cited by 72
Ouédraogo, G., Alépée, N., Tan, B., & Roper, C. S. (2025) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2025.105904 · Cited by 64
Development of Skin-On-A-Chip Platforms for Different Utilizations: Factors to Be Considered
Ponmozhi, J., Dhinakaran, S., Varga‐Medveczky, Z., Fónagy, K., Bors, L. A., Iván, K., & Erdő, F. (2021) · Micromachines · doi:10.3390/mi12030294 · Cited by 63
Parhi, R. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104395 · Cited by 54
Applicability of organ-on-chip systems in toxicology and pharmacology
Schneider, M. R., Oelgeschläger, M., Burgdorf, T., van Meer, P. J. K., Theunissen, P. T., Kienhuis, A. S., Piersma, A. H., & Vandebriel, R. J. (2021) · Critical Reviews in Toxicology · doi:10.1080/10408444.2021.1953439 · Cited by 53
Microphysiological Systems: Stakeholder Challenges to Adoption in Drug Development
Hargrove-Grimes, P., Low, L. A., & Tagle, D. A. (2022) · Cells Tissues Organs · doi:10.1159/000517422 · Cited by 48
Baker, T. K., Vleet, T. R. V., Mahalingaiah, P. K. S., Grandhi, T. S. P., Evers, R., Ekert, J. E., Gosset, J. R., Chacko, S. A., & Kopec, A. K. (2023) · Drug Metabolism and Disposition · doi:10.1124/dmd.123.001510 · Cited by 42
Sutterby, E., Thurgood, P., Baratchi, S., Khoshmanesh, K., & Pirogova, E. (2022) · VIEW · doi:10.1002/viw.20210012 · Cited by 41
Zingales, V., Esposito, M. R., Torriero, N., Taroncher, M., Cimetta, E., & Ruiz, M.-J. (2023) · Toxins · doi:10.3390/toxins15070422 · Cited by 40
Microphysiological systems: What it takes for community adoption
Hargrove-Grimes, P., Low, L. A., & Tagle, D. A. (2021) · Experimental Biology and Medicine · doi:10.1177/15353702211008872 · Cited by 35
Chen, Z., Kheiri, S., Gevorkian, A., Young, E. W. K., Andre, V., Deisenroth, T. W., & Kumacheva, E. (2021) · Lab on a Chip · doi:10.1039/d1lc00619c · Cited by 34
Tomlinson, L., Ramsden, D., Leite, S. B., Beken, S., Bonzo, J. A., Brown, P., Candarlioglu, P. L., Chan, T. S., Chen, E., Choi, C. K., et al. (2024) · Advanced Biology · doi:10.1002/adbi.202300131 · Cited by 33
Self-citationUgodnikov, A., Persson, H., & Simmons, C. A. (2024) · Lab on a Chip · doi:10.1039/d3lc01027a · Cited by 33
Research and Development of Microphysiological Systems in Japan Supported by the AMED-MPS Project
Ishida, S. (2021) · Frontiers in Toxicology · doi:10.3389/ftox.2021.657765 · Cited by 29
Complex in vitro models positioned for impact to drug testing in pharma: a review
Kang, S., Chen, E. C., Cifuentes, H., Co, J. Y., Cole, G., Graham, J. C., Hsia, I., Kiyota, T., Klein, J. A., Kroll, K. T., et al. (2024) · Biofabrication · doi:10.1088/1758-5090/ad6933 · Cited by 25
Opportunities for Microphysiological Systems in Toxicity Testing of New Drug Modalities
Maulana, T. I., Wevers, N. R., Kristoforus, T., Chandler, M. R., Lanz, H. L., Joore, J., Vulto, P., Villenave, R., Kustermann, S., Loskill, P., et al. (2024) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-061724-080621 · Cited by 24
The Combination of Cell Cultured Technology and In Silico Model to Inform the Drug Development
Zhou, Z., Zhu, J., Jiang, M., Sang, L., Hao, K., & He, H. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13050704 · Cited by 23
Kheiri, S., Chen, Z., Yakavets, I., Rakhshani, F., Young, E. W. K., & Kumacheva, E. (2023) · Biotechnology Journal · doi:10.1002/biot.202200621 · Cited by 21
Advances in tissue engineering and biofabrication for in vitro skin modeling
Wistner, S. C., Rashad, L., & Slaughter, G. E. (2023) · Bioprinting · doi:10.1016/j.bprint.2023.e00306 · Cited by 20
Lu, H., Zuo, X., Yuan, J., Xie, Z., Yin, L., Pu, Y., Chen, Z., & Zhang, J. (2024) · Journal of Applied Toxicology · doi:10.1002/jat.4618 · Cited by 18
Zhao, H., Chen, Z., Kang, X., Yang, B., Luo, P., Li, H., & He, Q. (2023) · Toxicological Sciences · doi:10.1093/toxsci/kfad093 · Cited by 18
In vitro 3D skin culture and its sustainability in toxicology: a narrative review
Masri, S., Fauzi, M. B., Rajab, N. F., Lee, W.-H., Zainal Abidin, D. A., & Siew, E. L. (2024) · Artificial Cells, Nanomedicine, and Biotechnology · doi:10.1080/21691401.2024.2407617 · Cited by 15
“The primary objective of the tiered approach to skin corrosion and irritation evaluation outlined in the International Air Transport Association (IATA) is to high-light the utilization of animal testing as a final option [4].”
Gan, J., Bolon, B. N., Vleet, T. V., & Wood, C. E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821044-4.00005-4 · Cited by 15
Garralaga, M. P., Lomba, L., Zuriaga, E., Santander, S., & Giner, B. (2022) · Applied Sciences · doi:10.3390/app122211710 · Cited by 14
Assessment of Skin Toxicity in an in Vitro Reconstituted Human Epidermis Model Using Deep Learning
Hu, F., Santagostino, S. F., Danilenko, D. M., Tseng, M., Brumm, J., Zehnder, P., & Wu, K. C. (2022) · The American Journal of Pathology · doi:10.1016/j.ajpath.2021.12.007 · Cited by 13
Gomez, P. D. L. S., Rai, R., Ritchie, P., Smith, L. A., Simpson, A., Goncalves, K., & Przyborski, S. A. (2025) · Journal of Anatomy · doi:10.1111/joa.70026 · Cited by 12
Yamazaki, D., & Ishida, S. (2024) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2024.101047 · Cited by 11
Weener, H. J., Middelkamp, H. H. T., & Van der Meer, A. D. (2024) · Frontiers in Toxicology · doi:10.3389/ftox.2024.1513002 · Cited by 10
Devine, P. J., Ekert, J. E., Kopec, A. K., Stresser, D. M., Ramsden, D., Szilagyi, J. T., Hewitt, P. G., Hardwick, R. N., Laing, S. T., Vleet, T. R. V., et al. (2025) · ALTEX · doi:10.14573/altex.2407122 · Cited by 10
Self-citationA multi-strain human skin microbiome model provides a testbed for disease modeling
Maloney, A. L., Crawford, T., Hurlbut, J., Martinez, M., Mulhern, T. J., Wiellette, E. L., Vedula, E. M., & Vijayakumar, V. (2025) · Frontiers in Microbiomes · doi:10.3389/frmbi.2025.1473292 · Cited by 9
Saini, K., Arora, C., Saini, M., Sharma, S., Chitkara, D., & Kakkar, V. (2022) · Food and Chemical Toxicology · doi:10.1016/j.fct.2022.113260 · Cited by 8
Genetic variants affecting chemical mediated skin immunotoxicity
de Souza, I. R., de Araujo‐Souza, P. S., & Leme, D. M. (2022) · Journal of Toxicology and Environmental Health Part B · doi:10.1080/10937404.2021.2013372 · Cited by 6
Development of iPSC-derived full-thickness human skin via droplet-based 3D bioprinting
Baek, J., Hong, Y., Lee, D., Roh, A. H., Kim, C., Chung, H. M., Lee, J.-H., & Jeon, K. (2025) · Bioprinting · doi:10.1016/j.bprint.2025.e00445 · Cited by 6
LaFollette, M. R., Baran, S. W., Curley, J. L., Dickinson, A. M., Frazier, T. P., Hobi, N., Huang, M.-I., Hutter, V., Maisonneuve, B. G. C., Marsh, G., et al. (2025) · Alternatives to Laboratory Animals · doi:10.1177/02611929241310566 · Cited by 5
Lang, S., Lin, X., Wang, S., Sun, W., Yang, Y., Chen, Y., Bao, Z., Feng, W., Wang, Y., & Luo, Y. (2025) · Environment & Health · doi:10.1021/envhealth.5c00072 · Cited by 4
Panzarini, E., Carata, E., Mariano, S., Tenuzzo, B. A., Tacconi, S., Fidaleo, M., & Dini, L. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823394-8.00007-x · Cited by 2
Lefojane, R. P., Adegoke, A. M., & Sekhoacha, M. P. (2026) · Journal of Nanotechnology · doi:10.1155/jnt/9602295 · Cited by 2
Gadhar, S., Chechang, S., Sales, P., & Arany, P. R. (2023) · PeerJ Materials Science · doi:10.7717/peerj-matsci.30 · Cited by 2
Stability and Safety Analysis of Statin-Loaded Nano-films for the Treatment of Diabetic Wound
Rasool, M., Alotaibi, N., Sarfraz, M., & Siddique, M. I. (2024) · Sains Malaysiana · doi:10.17576/jsm-2024-5301-16 · Cited by 1
Hydrogels and microfluidics: toward more physiologically relevant organ-on-a-chip models
Taromian, F., Mahmoudi, N., Aguilar, L. C., Stamp, M. E. M., Collins, D. J., & Nisbet, D. R. (2026) · Lab on a Chip · doi:10.1039/d6lc00628k
Catarino, R. I. L., Sobral, B., Pimenta, A. M., Souto, M. R. S., & Silva, F. A. M. (2026) · Applied Sciences · doi:10.3390/app16178855
Skin and nanotoxicity: An overview
Chandra, P., Sachan, N., Pathak, R., Sharma, H., & Rahman, M. A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-36326-9.00015-0
Montenegro, B. M., Gonçalves, R. M., Pegurier, M., Amorim, I., Rossi, A. M., & Baptista, L. S. (2026) · Journal of Applied Toxicology · doi:10.1002/jat.70057
Zanatelli, C., Pretto, L., Paim, T. C., & Wink, M. R. (2026) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2026.10032
Kumari, P., & Kakkar, V. (2025) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5c00930
Mayans, A. M. (2020) · RiuNet (Universitat Politècnica de València)
Gadhar, S., Chechang, S., Sales, P., & Arany, P. (2023) · doi:10.7717/peerj-matsci.30/supp-2
Díaz-Román, M. A., Ríos-Gómez, R., Acevedo‐Fernández, J. J., Rios, M. Y., & Aguilar‐Guadarrama, A. B. (2026) · Stresses · doi:10.3390/stresses6030044
Metadata
- Authors
- Hardwick, R. N., Betts, C. J., Whritenour, J., Sura, R., Thamsen, M., Kaufman, E. H., & Fabre, K.
- Affiliations
- Theravance Biopharma (United States) (US)
- AstraZeneca (United Kingdom) (GB)
- Pfizer (United States) (US)
- AbbVie (United States) (US)
- Corresponding author
- Hardwick, Rhiannon N.
- Venue
- Lab on a Chip
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2020
- Volume
- 20
- Issue
- 2
- Pages
- 199-214
- ISSN
- 1473-0189 (ISSN-L)
- 1473-0197
- OpenAlex
- W2979806580
- Cited by
- 48
- References
- 73
- Citations by year
- 2026: 4 · 2025: 8 · 2024: 7 · 2023: 10 · 2022: 5 · 2021: 10 · 2020: 4
- FWCI
- 0.38
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Lab on a Chip (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Health Sciences › Medicine › Dermatology › Contact Dermatitis and Allergies
- Keywords
- drug-induced skin toxicity, microphysiological systems, organ-on-a-chip, skin organoids, skin irritation, skin corrosion, skin sensitization, percutaneous absorption, phototoxicity, genotoxicity, hair follicle, innervation, drug development
- MeSH terms
- Drug Development, Animals, Drug Industry, Pharmaceutical Preparations, Humans, Models, Biological, Skin, Lab-On-A-Chip Devices
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.